| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 937 | 2018 |
| Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice T Kaifu, J Nakahara, M Inui, K Mishima, T Momiyama, M Kaji, A Sugahara, ... The Journal of clinical investigation 111 (3), 323-332, 2003 | 377 | 2003 |
| Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy Y Watanabe, A Uruha, S Suzuki, J Nakahara, K Hamanaka, K Takayama, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (10), 1038-1044, 2016 | 295 | 2016 |
| Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys Y Nagai, N Miyakawa, H Takuwa, Y Hori, K Oyama, B Ji, M Takahashi, ... Nature neuroscience 23 (9), 1157-1167, 2020 | 216 | 2020 |
| Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients S Suzuki, A Nishikawa, M Kuwana, H Nishimura, Y Watanabe, ... Orphanet journal of rare diseases 10, 1-9, 2015 | 214 | 2015 |
| Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy J Nakahara, M Maeda, S Aiso, N Suzuki Clinical reviews in allergy & immunology 42, 26-34, 2012 | 198 | 2012 |
| Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis J Nakahara, K Kanekura, M Nawa, S Aiso, N Suzuki The Journal of clinical investigation 119 (1), 2008 | 157 | 2008 |
| Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial S Misawa, S Kuwabara, Y Sato, N Yamaguchi, K Nagashima, K Katayama, ... The Lancet Neurology 17 (6), 519-529, 2018 | 154 | 2018 |
| Skeletal muscle involvement in antisynthetase syndrome E Noguchi, A Uruha, S Suzuki, K Hamanaka, Y Ohnuki, J Tsugawa, ... JAMA neurology 74 (8), 992-999, 2017 | 148 | 2017 |
| Bisphenol A exerts thyroid-hormone-like effects on mouse oligodendrocyte precursor cells C Seiwa, J Nakahara, T Komiyama, Y Katsu, T Iguchi, H Asou Neuroendocrinology 80 (1), 21-30, 2004 | 95 | 2004 |
| Inflammatory myopathy associated with PD-1 inhibitors M Seki, A Uruha, Y Ohnuki, S Kamada, T Noda, A Onda, M Ohira, A Isami, ... Journal of autoimmunity 100, 105-113, 2019 | 93 | 2019 |
| Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation J Nakahara, K Tan-Takeuchi, C Seiwa, M Gotoh, T Kaifu, A Ujike, M Inui, ... Developmental cell 4 (6), 841-852, 2003 | 73 | 2003 |
| Application of q-space diffusion MRI for the visualization of white matter K Fujiyoshi, K Hikishima, J Nakahara, O Tsuji, J Hata, T Konomi, T Nagai, ... Journal of Neuroscience 36 (9), 2796-2808, 2016 | 70 | 2016 |
| Electroconvulsive therapy for Parkinson's disease: A systematic review and meta‐analysis A Takamiya, M Seki, S Kudo, T Yoshizaki, J Nakahara, M Mimura, ... Movement Disorders 36 (1), 50-58, 2021 | 63 | 2021 |
| HLA-DRB1 alleles in immune-mediated necrotizing myopathy Y Ohnuki, S Suzuki, T Shiina, A Uruha, Y Watanabe, S Suzuki, S Izumi, ... Neurology 87 (18), 1954-1955, 2016 | 63 | 2016 |
| Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice M Kawasumi, T Chiba, M Yamada, M Miyamae‐Kaneko, M Matsuoka, ... European Journal of Neuroscience 19 (10), 2826-2838, 2004 | 61 | 2004 |
| Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study JF Howard, S Bresch, A Genge, C Hewamadduma, J Hinton, Y Hussain, ... The Lancet Neurology 22 (5), 395-406, 2023 | 57 | 2023 |
| Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study K Sekiguchi, N Watanabe, N Miyazaki, K Ishizuchi, C Iba, Y Tagashira, ... Cephalalgia 42 (3), 266-272, 2022 | 49 | 2022 |
| Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies T Tezuka, K Takahata, M Seki, H Tabuchi, Y Momota, M Shiraiwa, ... Brain Communications 3 (4), fcab190, 2021 | 43 | 2021 |
| Atrial fibrillation-associated ischemic stroke patients with prior anticoagulation have higher risk for recurrent stroke K Tanaka, M Koga, KJ Lee, BJ Kim, EL Park, J Lee, T Mizoguchi, ... Stroke 51 (4), 1150-1157, 2020 | 42 | 2020 |
